戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  with 12 female volunteers who had never had bulimia.
2     OCD symptoms persist after recovery from bulimia.
3 elated and contribute to the pathogenesis of bulimia.
4 mptoms persist after long-term recovery from bulimia.
5 r between alcohol dependence and anorexia or bulimia.
6 se of procedural justice than did those with bulimia.
7  examined the benefits of two treatments for bulimia: 1) fluoxetine, an antidepressant medication, an
8 ine dependence but not alcohol dependence or bulimia; (2) greater number of episodes, more impairment
9 l disorders, the highest ORs being seen with bulimia and alcohol and other drug dependence.
10 therapy may also be applicable to adolescent bulimia and binge eating.
11                                   Women with bulimia and those who had recovered from bulimia had sim
12 such as neurodegenerative diseases, obesity, bulimia, and anorexia nervosa.
13 ssions of OCD, the binge eating behaviors of bulimia, and the self-starvation of anorexia.
14 olics after controlling for other disorders, bulimia did occur at a greater than expected rate.
15 subscales of the Eating Disorders Inventory (bulimia, drive for thinness, maturity fears, perfectioni
16 lting positive feedback cycle escalates into bulimia for many, and anorexia in a few.
17 ervosa, 29 women who had been recovered from bulimia for more than 1 year, and 19 healthy female comp
18 ith bulimia and those who had recovered from bulimia had similar Yale-Brown scale scores and endorsed
19 he Yale-Brown scale scores of the women with bulimia (mean = 13.1, SD = 10.6) and those who had recov
20  SD = 10.6) and those who had recovered from bulimia (mean = 7.9, SD = 7.0) were significantly higher
21 ong, positive dose-response association with bulimia nervosa (adjusted hazard ratio = 1.15, 95% confi
22             We enrolled patients with severe bulimia nervosa (at least seven coupled binge/vomit epis
23 hotherapy in reducing behavioral symptoms of bulimia nervosa (binge eating and vomiting).
24 on in anorexia nervosa (AN) or overeating in bulimia nervosa (BN) a form of addiction?
25                    Anorexia nervosa (AN) and bulimia nervosa (BN) are disorders characterized by abno
26 ED data are presented here and compared with bulimia nervosa (BN) data in the World Health Organizati
27                                              Bulimia nervosa (BN) has been associated with dysregulat
28                                   Women with bulimia nervosa (BN) have disturbances of mood and behav
29                                              Bulimia nervosa (BN) is strongly familial, and additive
30 t as follows: Anorexia Nervosa (AN) n = 171; Bulimia Nervosa (BN) n = 82; Recovered AN n = 90; Health
31 trol circuits in adolescents and adults with bulimia nervosa (BN), but less is known about the micros
32 disorders, such as anorexia nervosa (AN) and bulimia nervosa (BN), have genetic and environmental und
33 in adolescent and adult female subjects with bulimia nervosa (BN).
34 =13.9), significantly longer than for either bulimia nervosa (mean=5.8 years, SD=9.1) or anorexia ner
35  either DSM-IV anorexia nervosa (n = 136) or bulimia nervosa (n = 110) between January 1, 1987, and D
36 ficantly diminished and women recovered from bulimia nervosa (N=14) had significantly elevated hemody
37  as there were about anorexia nervosa and/or bulimia nervosa (N=169).
38  diagnoses of binge eating disorder (N=131), bulimia nervosa (N=17), and anorexia nervosa (N=18).
39 ing-type anorexia nervosa (N=24), women with bulimia nervosa (N=19), and healthy comparison women (N=
40      Women diagnosed with either anorexia or bulimia nervosa (N=246) completed prospective evaluation
41  with restricting anorexia nervosa (n=26) or bulimia nervosa (n=47), control women (n=44), and first-
42 5 individuals with anorexia nervosa (N=177), bulimia nervosa (N=906), or eating disorder not otherwis
43  to assess diagnoses of anorexia nervosa and bulimia nervosa (per DSM-IV and broad criteria).
44 .38-9.54] vs adjusted, 2.67 [1.78-4.01]) and bulimia nervosa (suicide attempts: crude, 6.26 [5.73-6.8
45 inin release compared with participants with bulimia nervosa (t(76.44) = 2.51; P = .01) and did not d
46            Nine women who had recovered from bulimia nervosa (they had no episodes of binge eating or
47 ervosa among women might be up to 4%, and of bulimia nervosa 2%.
48                             Eight women with bulimia nervosa and 10 age- and weight-matched control s
49 d, medication-free, normal-weight women with bulimia nervosa and 14 age-matched healthy female contro
50 ndent response in 18 female adolescents with bulimia nervosa and 18 healthy female age-matched subjec
51                             Eight women with bulimia nervosa and 8 female controls underwent brain MR
52  found empirical support for conceptualizing bulimia nervosa and binge eating disorder as discrete sy
53 y remain the most established treatments for bulimia nervosa and binge eating disorder, with stepped-
54 utrient and food group intakes of women with bulimia nervosa and binge-eating disorder during pregnan
55  to measure the prevalence and correlates of bulimia nervosa and bulimic behaviors in a sample of und
56 nal distress compared with participants with bulimia nervosa and controls.
57 ialization affects the risk for anorexia and bulimia nervosa and disordered eating in members of oppo
58 ality ratios were significantly elevated for bulimia nervosa and eating disorder not otherwise specif
59 ndardized mortality ratios were elevated for bulimia nervosa and eating disorder not otherwise specif
60  compare serotonin function in patients with bulimia nervosa and healthy controls.
61 ell-validated disorders anorexia nervosa and bulimia nervosa and likely represents a stable syndrome.
62 n appear less likely to exhibit anorexia and bulimia nervosa and more likely to exhibit binge eating
63 cles published about anorexia nervosa and/or bulimia nervosa and the number of articles published abo
64 t while menstrual irregularities are common, bulimia nervosa appears to have little impact on later a
65 ecovery rates for DSM-5 anorexia nervosa and bulimia nervosa are 69 and 55%, respectively; little is
66                    Both anorexia nervosa and bulimia nervosa are associated with increased mortality.
67                         Anorexia nervosa and bulimia nervosa are common and severe eating disorders (
68                         Anorexia nervosa and bulimia nervosa are common problems facing adolescents a
69                    Both anorexia nervosa and bulimia nervosa are familial.
70 -based treatment trials for adolescents with bulimia nervosa are largely absent.
71        These results support the validity of bulimia nervosa as a diagnostic category that is distinc
72 ht to investigate the predictive validity of bulimia nervosa as a diagnostic category.
73 ivate to the same degree in adolescents with bulimia nervosa as in healthy comparison subjects.
74                                   Women with bulimia nervosa before and during pregnancy and those wi
75                  Women with the diagnosis of bulimia nervosa between 1981 and 1987 who participated i
76 itudinal distinction of anorexia nervosa and bulimia nervosa but do not support the anorexia nervosa
77 er mistakes was associated with anorexia and bulimia nervosa but not with other psychiatric disorders
78 ubtypes over time; one-third crossed over to bulimia nervosa but were likely to relapse into anorexia
79 ed in participants with purging disorder and bulimia nervosa compared with controls but did not diffe
80 ognize hunger signals, whereas overeating in bulimia nervosa could represent an exaggerated perceptio
81 women who continue to meet full criteria for bulimia nervosa declines as the duration of follow-up in
82  zygosity; the prevalence of DSM-IV or broad bulimia nervosa did not differ in women from opposite- v
83 essary to resolve conflict, adolescents with bulimia nervosa displayed abnormal patterns of activatio
84 tine versus placebo in preventing relapse of bulimia nervosa during a 52-week period after successful
85 howed symptoms of either anorexia nervosa or bulimia nervosa during pregnancy had a higher frequency
86 ple of individuals with anorexia nervosa and bulimia nervosa from the Price Foundation collaborative
87 a nervosa groups and on the left side in the bulimia nervosa group relative to the healthy comparison
88 educed in the recovered anorexia nervosa and bulimia nervosa groups and predicted sensitivity to rewa
89                 Women who had recovered from bulimia nervosa had a reduction of medial orbital fronta
90 mately 50% of women initially diagnosed with bulimia nervosa had fully recovered from their disorder,
91                      In addition, women with bulimia nervosa had less activation in the lateral and a
92                                           As bulimia nervosa has been associated with a dysregulated
93 tions decrease binge eating in patients with bulimia nervosa has fueled interest in the hypothesis th
94      Recent research on Anorexia Nervosa and Bulimia Nervosa has yielded an increasingly detailed und
95                           Two treatments for bulimia nervosa have emerged as having established effic
96               The treatment of patients with bulimia nervosa in a primary care setting is hampered by
97 haviours in patients with severe and chronic bulimia nervosa in a randomised, double-blind, placebo-c
98 g the usefulness of family interventions for bulimia nervosa in adolescents.
99 ervosa and possibly lower incidence rates of bulimia nervosa in Caucasian North American and Northern
100 on; and increasing rates of binge eating and bulimia nervosa in Hispanic and Black American minority
101                                              Bulimia nervosa in men was too rare to be assessed by zy
102 ta on outcome for individuals diagnosed with bulimia nervosa in order to better understand long-term
103 whether treatments known to be effective for bulimia nervosa in specialized treatment centers can be
104 due to all causes of death for subjects with bulimia nervosa in these studies was 0.3% (seven deaths
105                                              Bulimia nervosa is a common eating disorder in adolescen
106                              The etiology of bulimia nervosa is complex, with biologic, psychological
107 acy of fluoxetine in the acute management of bulimia nervosa is well established; however, few contro
108 ver" among the anorexia nervosa subtypes and bulimia nervosa may reflect problems with the validity o
109 r of eating that appears to be distinct from bulimia nervosa on subjective and physiological response
110 th binge eating and purging behaviors (i.e., bulimia nervosa or anorexia nervosa, binge eating/purgin
111 ften useful as adjuncts to psychotherapy for bulimia nervosa or binge-eating disorder; in the case of
112 acial/ethnic difference in the prevalence of bulimia nervosa or bulimic behaviors; 1.5% of the whites
113 y (CBT) guided self-care in adolescents with bulimia nervosa or eating disorder not otherwise specifi
114                 Eighty-five adolescents with bulimia nervosa or eating disorder not otherwise specifi
115 were randomly assigned to family therapy for bulimia nervosa or individual CBT guided self-care suppo
116 isorders, 0.8% had partial- or full-criteria bulimia nervosa or purging disorder and 2.9% had partial
117        The participants were 80 mothers with bulimia nervosa or similar eating disorder who were atte
118                    A total of 120 women with bulimia nervosa participated in a randomized, placebo-co
119 mined menstrual and reproductive function in bulimia nervosa patients retrospectively, with 10-15-yea
120                 Adolescents with and without bulimia nervosa performed similarly on the task.
121 rial was conducted in which 70 patients with bulimia nervosa received either 2 years of weekly psycho
122   Long-term outcome for women diagnosed with bulimia nervosa remains unclear.
123 outcome studies of both anorexia nervosa and bulimia nervosa show that no significant differences exi
124 ompared with control subjects, patients with bulimia nervosa showed a blunting of postprandial cholec
125                             More research on bulimia nervosa specific to adolescence is needed.
126 h higher in people with anorexia nervosa and bulimia nervosa than in a nonclinical group of women in
127  in engendering improvement in patients with bulimia nervosa than IPT.
128 lescents and adults with anorexia nervosa or bulimia nervosa that, together, implicate dysregulation
129 sover longitudinally in anorexia nervosa and bulimia nervosa to inform the validity of the DSM-IV-TR
130  of the studies linking anorexia nervosa and bulimia nervosa to substance use disorders suffer from p
131            Cognitive behavioural therapy for bulimia nervosa was assigned grade A because of the evid
132 al behavior therapy adapted for treatment of bulimia nervosa was associated with a promising decrease
133                                              Bulimia nervosa was more common than anorexia nervosa in
134 obands; the corresponding relative risks for bulimia nervosa were 4.2 and 4.4 for female relatives of
135 enty patients meeting DSM-III-R criteria for bulimia nervosa were allocated at random to 19 sessions
136 en partial syndromes of anorexia nervosa and bulimia nervosa were considered, relative risks fell by
137 tes of full and partial anorexia nervosa and bulimia nervosa were determined in first-degree relative
138 omen with a diagnosis of anorexia nervosa or bulimia nervosa were followed for 7 years; weekly eating
139                          Antidepressants for bulimia nervosa were given grade B.
140                    A total of 173 women with bulimia nervosa were interviewed an average of 11.5 year
141 ing female patients with anorexia nervosa or bulimia nervosa were interviewed every 6 months for a me
142  who had recovered from anorexia nervosa and bulimia nervosa were studied to avoid confounding effect
143                                   Women with bulimia nervosa were unlikely to cross over to anorexia
144 th fluoxetine is useful for individuals with bulimia nervosa who do not respond to psychotherapy or r
145                     Twenty-two patients with bulimia nervosa who had not responded to, or had relapse
146 e study examined relapse in 48 patients with bulimia nervosa who had responded to cognitive behaviora
147 y be a useful intervention for patients with bulimia nervosa who have not responded adequately to psy
148 d treatment with fluoxetine in patients with bulimia nervosa who responded to acute treatment with fl
149 formation exists on relapse in patients with bulimia nervosa who responded with complete abstinence f
150 194 women meeting the DSM-III-R criteria for bulimia nervosa who were treated with 18 sessions of man
151 of attrition and outcome in the treatment of bulimia nervosa with cognitive behavior therapy.
152 e recorded (lifetime anorexia nervosa, N=14; bulimia nervosa with no history of anorexia nervosa, N=2
153 orexia nervosa and 2.33 (95% CI=0.3-8.4) for bulimia nervosa with no history of anorexia nervosa.
154 hout obsessive-compulsive features; and LC4, bulimia nervosa with self-induced vomiting as the sole f
155  (LC1) resembled restricting AN; LC2, AN and bulimia nervosa with the use of multiple methods of purg
156                                        Since bulimia nervosa's introduction to the psychiatric nomenc
157  (any eating disorder, anorexia nervosa, and bulimia nervosa) identified by any lifetime diagnoses re
158 alized anxiety disorder, panic disorder, and bulimia nervosa), and four were "externalizing" (nicotin
159 a nervosa and higher in women recovered from bulimia nervosa).
160 male patients with eating disorders (10 with bulimia nervosa, 16 with anorexia nervosa) and 19 health
161 0 years after they appeared as patients with bulimia nervosa, 177 women (participation rate=79.7%) co
162              Thirty-one female patients with bulimia nervosa, 29 women who had been recovered from bu
163 s), 11% of this sample met full criteria for bulimia nervosa, and 0.6% met full criteria for anorexia
164  individuals with anorexia nervosa, 282 with bulimia nervosa, and 293 with anorexia nervosa and bulim
165 tes were 4.0% for anorexia nervosa, 3.9% for bulimia nervosa, and 5.2% for eating disorder not otherw
166 ering the threshold for anorexia nervosa and bulimia nervosa, and adding BED as a specified eating di
167 examined the prevalence of anorexia nervosa, bulimia nervosa, and binge eating disorder in a geograph
168 me prevalence estimates of anorexia nervosa, bulimia nervosa, and binge-eating disorder were 0.3%, 0.
169  DSM-IV classifications of anorexia nervosa, bulimia nervosa, and binge-eating disorder.
170 current classifications of anorexia nervosa, bulimia nervosa, and binge-eating disorder.
171 1998 and followed them for anorexia nervosa, bulimia nervosa, and eating disorder not otherwise speci
172 y was to determine whether anorexia nervosa, bulimia nervosa, and eating disorder not otherwise speci
173       Research into treatment has focused on bulimia nervosa, and evidence-based management of this d
174 ssion and co-twin risk for anorexia nervosa, bulimia nervosa, and obesity.
175 miological studies, short-term treatment for bulimia nervosa, and outcome in anorexia nervosa.
176 ree diagnostic categories: anorexia nervosa, bulimia nervosa, and the atypical eating disorders.
177 g disorders, especially anorexia nervosa and bulimia nervosa, are more common among white women than
178 e four new categories are: anorexia nervosa, bulimia nervosa, binge eating disorder, and eating disor
179 ipants with a diagnosis of anorexia nervosa, bulimia nervosa, binge eating disorder, or eating disord
180 ), attention-deficit/hyperactivity disorder, bulimia nervosa, cataplexy, dysthymic disorder, fibromya
181 rs, but not the women who had recovered from bulimia nervosa, had an age-related decline in 5-HT(2A)
182                    Anorexia nervosa, but not bulimia nervosa, has one of the highest mortality rates
183  interventions are of established utility in bulimia nervosa, medications have no clear role in the t
184 a longitudinal study of anorexia nervosa and bulimia nervosa, now in its 12th year.
185 evidence that the risk for anorexia nervosa, bulimia nervosa, or disordered eating was associated wit
186 ot respond to cognitive behavior therapy for bulimia nervosa, potentially allowing early use of a sec
187         Patients who met DSM-IV criteria for bulimia nervosa, purging type, were assigned to single-b
188                            For patients with bulimia nervosa, the fenfluramine-stimulated increase in
189 en substantial advances in the management of Bulimia Nervosa, the goal of offering effective treatmen
190 ed to reward-processing deficits in remitted bulimia nervosa, the purpose of this study was to identi
191 h AN and related eating disorders, including bulimia nervosa, was performed, resulting in only modest
192  diagnostic criteria of anorexia nervosa and bulimia nervosa, which emphasize intrapsychic conflicts
193 onwhites (n = 693) were classified as having bulimia nervosa, while 5.5% of the whites and 5.3% of th
194 ory of a desensitized dopaminergic system in bulimia nervosa.
195 patterns were found for anorexia nervosa and bulimia nervosa.
196 l of the brain mu-opioid receptor (mu-OR) in bulimia nervosa.
197 r the compulsive eating behavior observed in bulimia nervosa.
198 entified as a common feature of anorexia and bulimia nervosa.
199 ty factor for developing anorexia nervosa or bulimia nervosa.
200 h (1.3; 95% confidence interval, 0.0-7.2) in bulimia nervosa.
201 ome in women diagnosed as having anorexia or bulimia nervosa.
202 sfunction occurs frequently in patients with bulimia nervosa.
203 aminergic dysfunction in the pathogenesis of bulimia nervosa.
204 more inpatient treatment than did women with bulimia nervosa.
205 apy to decrease binge and purge behaviors in bulimia nervosa.
206 ies for relapse of susceptible patients with bulimia nervosa.
207  version of psychoanalytic psychotherapy for bulimia nervosa.
208  present in patients who have recovered from bulimia nervosa.
209 erations in subjects who have recovered from bulimia nervosa.
210 behavioral therapy (CBT) in the treatment of bulimia nervosa.
211 n the pathophysiology of the eating disorder bulimia nervosa.
212 he preferred psychotherapeutic treatment for bulimia nervosa.
213 st effective psychotherapeutic treatment for bulimia nervosa.
214 mptoms are common in people who are ill with bulimia nervosa.
215 ilial aggregation was independent of that of bulimia nervosa.
216 ilial vulnerability for anorexia nervosa and bulimia nervosa.
217  have been implicated in the neurobiology of bulimia nervosa.
218 on of psychiatric disorders for anorexia and bulimia nervosa.
219  independent of that of anorexia nervosa and bulimia nervosa.
220 arly 20% continued to meet full criteria for bulimia nervosa.
221 is the psychological treatment of choice for bulimia nervosa.
222  questions based on the DSM-III criteria for bulimia nervosa.
223  for males, especially for those who develop bulimia nervosa.
224 observed deficit in satiety in patients with bulimia nervosa.
225 of abnormal eating patterns in patients with bulimia nervosa.
226  0.2% of the males were classified as having bulimia nervosa.
227  current diagnostic criteria for anorexia or bulimia nervosa.
228 ervosa and may be efficacious for youth with bulimia nervosa.
229 oral and neural reward-effort integration in bulimia nervosa.
230 eating in anorexia nervosa and overeating in bulimia nervosa.
231 norexia nervosa and promising for adolescent bulimia nervosa.
232 oods and avoid weight gain that characterize bulimia nervosa.
233  and conflict resolution in adolescents with bulimia nervosa.
234  including the subtypes anorexia nervosa and bulimia nervosa.
235 focused on the treatment of adolescents with bulimia nervosa.
236  determine how purging disorder differs from bulimia nervosa.
237 49 females (0.30%), and 61 males (0.01%) had bulimia nervosa.
238 ng disorders, including anorexia nervosa and bulimia nervosa.
239 ns and modifications to anorexia nervosa and bulimia nervosa; and the inclusion of binge eating disor
240 han black women (N=4, 0.4%) met criteria for bulimia nervosa; binge eating disorder also was more com
241 e a patient they were currently treating for bulimia or anorexia.
242 d greater acceptability for adolescents with bulimia or eating disorder not otherwise specified.
243 er, the types of OCD symptoms experienced by bulimia patients do not vary dramatically with improveme
244  Persistent OCD symptoms after recovery from bulimia raise the possibility that these behaviors are t
245                                              Bulimia status was assessed using criteria from the Diag
246 ng Disorder Inventory drive for thinness and bulimia subscales and depressed mood.
247 on and was operationalized using the Revised Bulimia Test.
248 ptor binding in women who had recovered from bulimia-type AN but not restricting-type AN.
249                         Women recovered from bulimia-type AN had significantly (P<.05) increased [11C
250 tively, for the alcohol-dependent women, and bulimia was observed in 1.35% of the alcoholic men.
251              Lifetime rates for anorexia and bulimia were 1.41% and 6.17%, respectively, for the alco
252  of the alcohol-dependent men; the rates for bulimia were 3.46% and 0.72%, respectively.
253 tric disorders, and symptoms of anorexia and bulimia were evaluated among alcohol-dependent probands,
254 a nervosa, and 293 with anorexia nervosa and bulimia were given the Structured Clinical Interview for
255                               Treatments for bulimia yield extremely high relapse rates, but cognitiv

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top